Honkamp Krueger Financial Services Inc. Raises Position in Stryker Co. (NYSE:SYK)

Honkamp Krueger Financial Services Inc. increased its holdings in Stryker Co. (NYSE:SYK) by 4.7% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,103 shares of the medical technology company’s stock after purchasing an additional 184 shares during the quarter. Honkamp Krueger Financial Services Inc.’s holdings in Stryker were worth $854,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. Founders Capital Management LLC lifted its holdings in Stryker by 3.9% during the second quarter. Founders Capital Management LLC now owns 10,887 shares of the medical technology company’s stock worth $2,238,000 after acquiring an additional 411 shares in the last quarter. Clarus Wealth Advisors lifted its holdings in shares of Stryker by 19.3% in the second quarter. Clarus Wealth Advisors now owns 2,111 shares of the medical technology company’s stock valued at $434,000 after purchasing an additional 342 shares in the last quarter. Bbva Compass Bancshares Inc. lifted its holdings in shares of Stryker by 1.1% in the first quarter. Bbva Compass Bancshares Inc. now owns 11,663 shares of the medical technology company’s stock valued at $2,304,000 after purchasing an additional 123 shares in the last quarter. MainStreet Investment Advisors LLC lifted its holdings in shares of Stryker by 3.9% in the first quarter. MainStreet Investment Advisors LLC now owns 15,532 shares of the medical technology company’s stock valued at $3,067,000 after purchasing an additional 589 shares in the last quarter. Finally, Advisory Services Network LLC lifted its holdings in shares of Stryker by 2.9% in the first quarter. Advisory Services Network LLC now owns 15,004 shares of the medical technology company’s stock valued at $2,963,000 after purchasing an additional 423 shares in the last quarter. Institutional investors own 74.14% of the company’s stock.

SYK stock traded down $4.17 during trading on Friday, hitting $214.10. The company had a trading volume of 739,692 shares, compared to its average volume of 1,063,063. The firm has a market capitalization of $81.66 billion, a P/E ratio of 29.29, a PEG ratio of 2.65 and a beta of 0.85. Stryker Co. has a 52-week low of $144.75 and a 52-week high of $222.59. The company has a 50 day simple moving average of $212.38 and a 200-day simple moving average of $196.13. The company has a quick ratio of 1.26, a current ratio of 2.07 and a debt-to-equity ratio of 0.67.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, July 25th. The medical technology company reported $1.98 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.05. The business had revenue of $3.65 billion for the quarter, compared to the consensus estimate of $3.60 billion. Stryker had a net margin of 24.99% and a return on equity of 25.98%. The company’s revenue for the quarter was up 9.9% on a year-over-year basis. During the same quarter last year, the firm posted $1.76 EPS. Sell-side analysts forecast that Stryker Co. will post 8.21 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 31st. Shareholders of record on Monday, September 30th will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 0.97%. The ex-dividend date is Friday, September 27th. Stryker’s payout ratio is 28.45%.

In related news, insider Timothy J. Scannell sold 4,666 shares of the business’s stock in a transaction on Tuesday, June 18th. The shares were sold at an average price of $197.68, for a total value of $922,374.88. Following the completion of the transaction, the insider now directly owns 155,347 shares in the company, valued at approximately $30,708,994.96. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Srikant M. Datar sold 350 shares of the business’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $215.00, for a total transaction of $75,250.00. Following the completion of the transaction, the director now owns 6,844 shares of the company’s stock, valued at $1,471,460. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 20,447 shares of company stock valued at $4,262,634. Company insiders own 7.20% of the company’s stock.

A number of analysts have recently commented on SYK shares. BMO Capital Markets set a $216.00 price target on Stryker and gave the company a “hold” rating in a report on Friday, July 26th. Credit Suisse Group boosted their price target on Stryker from $232.00 to $237.00 and gave the company an “outperform” rating in a report on Friday, July 26th. Piper Jaffray Companies boosted their price target on Stryker from $205.00 to $240.00 and gave the company an “overweight” rating in a report on Friday, July 26th. Raymond James set a $240.00 price target on Stryker and gave the company a “buy” rating in a report on Friday, July 26th. Finally, Barclays set a $226.00 price target on Stryker and gave the company a “buy” rating in a report on Friday, July 26th. Five analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $214.89.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Further Reading: Stop Order

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.